AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 21c ; Offers Guidance

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.53), $0.21 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $20.75 million.

GUIDANCE:

AVITA Medical, Inc. sees FY2025 revenue of $100-106 million, versus the consensus of $91.45 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• BMO Capital Upgrades Casey's General Stores (CASY) to Outperform, 'Opportunity Knocks'
• UBS Starts Liftoff Mobile (LFTO) at Buy
• H.C. Wainwright Upgrades Prime Medicine (PRME) to Buy